Advanced Non-small Cell Lung Cancer (NSCLC)
2 competing products in clinical development for Advanced Non-small Cell Lung Cancer (NSCLC).
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CS-7017 + erlotinib | Daiichi Sankyo | Phase 2 | Completed | 35 |
| ONO-4538 + ONO-4538 | Ono Pharmaceutical | Phase 2 | Completed | 35 |